The different mechanisms including activation of GPR41/43 and inhibition of HDACs by which SCFA influence endothelial function might be one way to explain these results and elucidating the inhibitory pathways induced by SCFA might open a new era in the treatment of (chronic) inflammatory (cardiovascular) diseases. The gene discussed is FFAR3; the disease is cardiovascular disorder.